Current state of femoral artery access technique

In the current issue of Cardiovascular Innovations and Applications (Volume3,Number 2, 2018, pp. 255-261(7); DOI: https://doi.org/10.15212/CVIA.2017.0061 Syed Raza Shah and Ki Park from UCF/HCA GME Consortium Internal Medicine, Gainesville, FL, USA and Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA consider the contemporary role of femoral artery access.

The scope of interventional cardiology has rapidly expanded over the last several decades. In a field where procedural treatment options for a variety of complex cardiovascular conditions have grown exponentially, the importance of procedural safety continues to come to the forefront. This is most evident in the movement toward radial access as the initial approach for operators in the cardiac catheterization laboratory. As the evidence grows for the superiority of radial access over femoral access with regard to reducing bleeding events and improving clinical outcomes, the authors discuss the modern approach to obtaining access, and highlight best practices.

CVIA is available on the IngentaConnect platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. CVIA is indexed in the ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ and Index Copernicus Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients